Orient Pharma Co., Ltd.
4166.TWO
Price:
$25.45
Market Cap:
$5.74B
Orient Pharma Co., Ltd. engages in the research and development, manufacturing, and sales of drugs in Taiwan and internationally. The company develops anti-psychotics and psychostimulants, as well as drugs for treating Parkinson's and Alzheimer's diseases; and products for the treatment of sialorrhea, tuberculosis, and attention deficit hyperactivity disorder. It is also developing drug delivery technologies, such as multi-stages-controlled release technology, trans-dermal patches, oral disintegrating tablets, sustained release technology, and micro granules. The company was founded in 2008 and is based in Taipei, Taiwan.
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2012-06-20
Stock Exchange
TWO
Ticker
4166.TWO
PE Ratio
[44.65]
ROE
[6.12%]
Current Ratio
[5.33]
Dividend Yield
[0%]
Enterprise Value
[5.40B]
Dividend History
The ROE as of December 2025 (TTM) for Orient Pharma Co., Ltd. (4166.TWO) is 6.12%
According to Orient Pharma Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is 6.12%. This represents a change of 310.80% compared to the average of 1.49% of the last 4 quarters.
Orient Pharma Co., Ltd. (4166.TWO) Historical ROE (quarterly & annually)
How has 4166.TWO ROE performed in the past?
The mean historical ROE of Orient Pharma Co., Ltd. over the last ten years is -6.50%. The current 6.12% ROE has changed -194.24% with respect to the historical average. Over the past ten years (40 quarters), 4166.TWO's ROE was at its highest in in the March 2025 quarter at 2.75%. The ROE was at its lowest in in the September 2022 quarter at -2.22%.
Average
-6.50%
Median
-5.92%
Minimum
-20.40%
Maximum
6.01%
Orient Pharma Co., Ltd. (4166.TWO) ROE by Quarter and Year
Discovering the peaks and valleys of Orient Pharma Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 350.20%
Maximum Annual ROE = 6.01%
Minimum Annual Increase = -150.56%
Minimum Annual ROE = -20.40%
| Year | ROE | Change |
|---|---|---|
| 2024 | 6.01% | 350.20% |
| 2023 | 1.33% | -150.56% |
| 2022 | -2.64% | -71.32% |
| 2021 | -9.20% | -34.65% |
| 2020 | -14.08% | -31.01% |
Orient Pharma Co., Ltd. (4166.TWO) Average ROE
How has 4166.TWO ROE performed in the past?
The current ROE of Orient Pharma Co., Ltd. (4166.TWO) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
1.57%
5-year avg
-3.71%
10-year avg
-6.50%
Orient Pharma Co., Ltd. (4166.TWO) ROE vs. Peers
How is 4166.TWO’s ROE compared to its peers?
Orient Pharma Co., Ltd.’s ROE is less than Panion & Bf Biotech Inc. (9.37%), less than BIONET Corp. (5.46%), greater than Easywell Biomedicals, Inc. (-9.28%), less than SCI Pharmtech, Inc. (2.12%), less than Formosa Optical Technology Co.,Ltd. (12.27%), less than Brighten Optix Corporation (5.12%), less than Ever Fortune.AI Co., Ltd. (6.47%), less than Hi-Clearance Inc. (11.74%), less than Savior Lifetec Corporation (13.48%), greater than Orient EuroPharma Co., Ltd. (-7.81%),
| Company | ROE | Market cap |
|---|---|---|
| 9.37% | $5.49B | |
| 5.46% | $5.01B | |
| -9.28% | $4.20B | |
| 2.12% | $5.90B | |
| 12.27% | $6.19B | |
| 5.12% | $5.41B | |
| 6.47% | $6.40B | |
| 11.74% | $6.10B | |
| 13.48% | $5.43B | |
| -7.81% | $3.77B |
Build a custom stock screener for Orient Pharma Co., Ltd. (4166.TWO) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Orient Pharma Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Orient Pharma Co., Ltd. (4166.TWO) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Orient Pharma Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Orient Pharma Co., Ltd.'s ROE?
How is the ROE calculated for Orient Pharma Co., Ltd. (4166.TWO)?
What is the highest ROE for Orient Pharma Co., Ltd. (4166.TWO)?
What is the 3-year average ROE for Orient Pharma Co., Ltd. (4166.TWO)?
What is the 5-year average ROE for Orient Pharma Co., Ltd. (4166.TWO)?
How does the current ROE for Orient Pharma Co., Ltd. (4166.TWO) compare to its historical average?